Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02110992 · ClinicalTrials.gov registry record · Phase 1
Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck
A Phase 1 study, sponsored by University of Cincinnati.
- Terminated
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT02110992: Clinical Trial Phase 1 study, sponsored by University of Cincinnati.
NCT02110992 is a Phase 1 study that was terminated before completion, run by University of Cincinnati. The registered enrollment target is 7 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02110992, a Phase 1 study, was terminated before completion, sponsored by University of Cincinnati.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this research study is to test the safety of a chemotherapy drug called docetaxel and focused radiation therapy (SBRT) and see what effects (good and bad) it has on recurrent head and neck cancer that is not surgically removable.
Primary Outcome
Acute dose limiting toxicity is defined as grade 4 or 5 toxicity measured by the Common Toxicity Criteria for Adverse Effects (CTCAE) v 4.0, including carotid arterial rupture
Interventions
- DRUG Docetaxel
- RADIATION Stereotactic Radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-04 |
| Est. Completion | 2017-03-29 |
| Phase | Phase 1 |
Why NCT02110992 stopped before completion
NCT02110992 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Docetaxel is the first listed.
NCT02110992 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02110992 about?
NCT02110992 is a clinical study titled "Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck". The purpose of this research study is to test the safety of a chemotherapy drug called docetaxel and focused radiation therapy (SBRT) and see what effects (good and bad) it has on recurrent head and neck cancer that is not surgically removable.
What is the current status of trial NCT02110992?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2014-04. Estimated completion is 2017-03-29.
What interventions are being tested in trial NCT02110992?
The interventions under investigation include: Docetaxel (DRUG), Stereotactic Radiation (RADIATION).
Who is sponsoring clinical trial NCT02110992?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02110992's enrollment target sits among peer trials
7 1972nd of 2000 higher than 27 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia